Astellas Pharma Inc.
ALPMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $535 | $68,422 | $74,896 | -$97,660 |
| Dep. & Amort. | $320 | $47,804 | $47,683 | $51,164 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $586 | -$47,168 | -$22,465 | -$72,155 |
| Other Non-Cash | $110 | -$68,670 | $961 | $134,677 |
| Operating Cash Flow | $1,551 | $54,837 | $101,075 | $16,026 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$224 | -$12,808 | -$9,699 | $2,294 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $122 | $12,685 | $6,734 | -$33,016 |
| Investing Cash Flow | -$103 | -$123 | -$2,965 | -$30,722 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,014 | -$10,386 | -$23,547 | -$15,568 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | -$727 | -$1 | -$1 |
| Dividends Paid | $0 | -$66,241 | $0 | -$66,234 |
| Other Fin. Act. | $35 | $77,277 | -$67,264 | -$22,493 |
| Financing Cash Flow | -$978 | -$77 | -$90,812 | -$104,296 |
| Forex Effect | -$24 | $51 | $1,209 | $5,865 |
| Net Chg. in Cash | $446 | $215,399 | $8,507 | $179,865 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,495 | $0 | $179,865 | $0 |
| End Cash | $1,940 | $215,399 | $188,372 | $179,865 |
| Free Cash Flow | $1,461 | $42,029 | $91,376 | $18,320 |